Ongoing Investigator-Initiated Clinical Trials

2022

Cognitive reserve-building activities in MS (CRAMS study)

2021

Rituximab and ocrelizumab treatment of active MS (DanNORMS study)

2021

The effect of a gluten free diet on the permeability of the blood brain barrier in patients with CIS

2021

Autologous hematopoietic stem cell transplantation versus alemtuzumab in MS (RAM-MS)

2021

The effect of medical cannabis on neuropathic pain and spasticity in patients with MS

Completed Investigator-Initiated Clinical Trials

The year refers to the date of publication (PubMed)

2020

Dimethyl fumarate treatment of primary progressive MS (FUMAPMS study)

2017

Erythropoietin treatment of progressive MS  

2016

Minocycline added to subcutaneous interferon β-1a in treatment of relapsing MS (RECYCLINE study) 

2016

Methylprednisolone treatment of progressive MS (COMTIMS study)

2015

Trichuris suis ova treatment of relapsing MS

2014

Natalizumab treatment of progressive MS (NAPMS study)

2013

Interferon-alfa for patients with neutralizing interferon-beta antibodies (REPAIR study)

2011

Simvastatin as an add-on therapy to interferon-beta1a for relapsing MS (SIMBOMBIN study)

2011

Simvastatin tretament of patients with opticus neuritis

2010

Combination therapy of methylprednisolone with interferon-beta for relapsing MS (MECOMBIN study)

2009

Combination therapy of methylprednisolone with interferon-beta for relapsing MS (NORMIMS study)

2009

Methylprednisolone and azathioprine for neutralizing antibodies to interferon-beta in patients with MS

2009

Methylprednisolone for neutralizing antibodies to interferon-beta in patients with MS

2006

The efficacy of two IFN-beta treatments in relapsing MS 

2004

Subcutanous IFN-beta 1-alpha in secondary progressive MS 

2004

IV immunoglobulins as add-on treatment to methyl predinisolone for acute relapses in MS

1999

Methylprednisolone treatment of optic neuritis

1998

Methylprednisolone treatment in attacks of MS

1996

Plasma exchange combined with azathioprine in secondary progressive MS 

1993

Prednisolone treatment of acute opticus neuritis